Middle East & Africa Blood Transfusion Diagnostics Market Forecast to 2028

Report Code : BMIRE00027421 | Region : LAMEA | Industry : Medical Device | Published Date : 11/Nov/2022
Middle East & Africa Blood Transfusion Diagnostics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Instruments & Kits and Reagents), Application (Blood Grouping and Disease Screening), and End User (Hospitals, Diagnostic Laboratories, Blood Banks, and Plasma Fractionation Companies)

The MEA blood transfusion diagnostics market is expected to grow from US$ 151.99 million in 2022 to US$ 199.02 million by 2028. It is estimated to grow at a CAGR of 4.6% from 2022 to 2028.

Technological Developments in Blood Transfusion Diagnostics to Brings New Trends to Market

Blood transfusion diagnostics are usually deployed during long-hour surgeries, such as kidney transplants, and in cases of emergencies. These surgeries are associated with the chances of excessive blood loss, which makes it difficult to make up for the blood loss with new blood, especially in the case of rare blood groups. Due to the ample demand, key players in the blood transfusion diagnostics market are offering advanced and fully automated blood transfusion diagnostics that reduce human interventions. For instance, in April 2019, BD launched its BD BACTEC quality control media to help identify contaminated platelet units during transfusions. Many companies employ strategic activities, such as acquisitions and partnerships, to capture better shares in the market. In December 2019, Getinge purchased Applikon Biotechnology, a leader in the development and supply of innovative bioreactor systems suitable for all scales, ranging from laboratory to industrial. In October 2019, Medtronic acquired AV Medical Technologies. Such advancements are likely to bring new trends in the blood transfusion diagnostics market in the coming years.

Market Overview

In 2021, South Africa held the largest share of the blood transfusion diagnostics market in the MEA. The country records the increasingly high incidence of various chronic diseases, such as diabetes, cancer, cardiovascular, and infectious diseases, requiring surgical procedures as a treatment. Also, healthcare facilities in South Africa are developing and adopting the latest technologies to offer better treatments. An article titled "Improving Sepsis Care in Africa, 2021" estimated that ~85% of sepsis cases occur in low and middle-income countries, with the highest burden in Africa. In addition, children (especially newborns), pregnant women, and elderly people are the most affected population. In Africa, ~17 million cases and 3.5 million deaths occurred in 2017 due to sepsis. Further, the increasing cases of sickle cell anemia (SCD) and thalassemia in South Africa are likely to complement the blood transfusion diagnostics market in South Africa. According to data published in Pan African Medical Journal, the World Health Organization (WHO) estimates ~50 million people with sickle cell trait globally, with the cases reaching 38 million in sub-Saharan Africa; Africa has 500,000 children with sickle cell disease, and 70% die before they turn 5 years of age, due to the lack of adequate care. SCD patients frequently require a blood transfusion, which can be associated with the increased demand for blood transfusion diagnostics in the country.

MEA Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

MEA Blood Transfusion Diagnostics Market Segmentation

The MEA blood transfusion diagnostics market is segmented based on product, application, end user, and country.

Based on product, the MEA blood transfusion diagnostics market is bifurcated into instruments & kits and reagents. The instruments & kits segment held the larger market share in 2022. Based on application, the MEA blood transfusion diagnostics market is bifurcated into blood grouping and disease screening. The disease screening segment held the larger market share in 2022. Based on end user, the MEA blood transfusion diagnostics market is segmented into hospitals, diagnostic laboratories, blood banks, and plasma fractionation companies. The blood banks segment dominated the market in 2022. Based on country, the MEA blood transfusion diagnostics market has been categorized into the UAE, Saudi Arabia, South Africa, and Rest of the MEA. Our regional analysis states that South Africa dominated the market in 2022. Abbott; BAG Diagnostics GmbH; Bio-Rad Laboratories, Inc.; DiaSorin S.p.A.; F. Hoffmann-La Roche Ltd; Grifols, S.A.; Immucor, Inc.; Ortho Clinical Diagnostics (QuidelOrtho Corporation); Quotient Limited; and Thermo Fisher Scientific Inc. are the leading companies operating in the MEA blood transfusion diagnostics market.

The List of Companies - Middle East & Africa Blood Transfusion Diagnostics Market

● Abbott

● BAG Diagnostics GmbH

● Bio-Rad Laboratories, Inc.

● DiaSorin S.p.A.

● F. Hoffmann-La Roche Ltd      

● Grifols, S.A.  

● Immucor, Inc.  

● Ortho Clinical Diagnostics (QuidelOrtho Corporation)

● Quotient Limited

● Thermo Fisher Scientific Inc.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 MEA Blood Transfusion Diagnostics Market – By Product

1.3.2 MEA Blood Transfusion Diagnostics Market – By Application

1.3.3 MEA Blood Transfusion Diagnostics Market – By End User

1.3.4 MEA Blood Transfusion Diagnostics Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. MEA Blood Transfusion Diagnostics Market – Market Landscape

4.1 Overview

4.2 MEA PEST Analysis

4.3 Experts Opinion

5. MEA Blood Transfusion Diagnostics Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rapid Increase in Chronic Diseases

5.1.2 Need for Blood Transfusion due to Rise in Organ Transplants Surgeries

5.2 Market Restraints

5.2.1 Problems Associated with Blood Transfusion Services

5.3 Market Opportunities

5.3.1 Elevated Healthcare Expenditure in Emerging Economies

5.4 Future Trends

5.4.1 Technological Developments in Blood Transfusion Diagnostics

5.5 Impact Analysis

6. Blood Transfusion Diagnostics Market– MEA Analysis

6.1 MEA Blood Transfusion Diagnostics Market Revenue Forecast and Analysis

7. MEA Blood Transfusion Diagnostics Market Analysis – By Product

7.1 Overview

7.2 MEA Blood Transfusion Diagnostics Market Revenue Share, by Product (2021 and 2028)

7.3 Instruments and Kits

7.3.1 Overview

7.3.2 Instruments and Kits: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

7.4 Reagents

7.4.1 Overview

7.4.2 Reagents: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

8. MEA Blood Transfusion Diagnostics Market Analysis – By Application

8.1 Overview

8.2 MEA Blood Transfusion Diagnostics Market Revenue Share, by Application (2021 and 2028)

8.3 Disease Screening

8.3.1 Overview

8.3.2 Disease Screening: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

8.4 Blood Grouping

8.4.1 Overview

8.4.2 Blood Grouping: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9. MEA Blood Transfusion Diagnostics Market Analysis – By End User

9.1 Overview

9.2 MEA Blood Transfusion Diagnostics Market Share, by End User, 2021 and 2028, (%)

9.3 Blood Banks

9.3.1 Overview

9.3.2 Blood Banks: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)

9.4 Hospitals

9.4.1 Overview

9.4.2 Hospitals: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9.5 Diagnostic Laboratories

9.5.1 Overview

9.5.2 Diagnostic Laboratories: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)

9.6 Plasma Fractionation Companies

9.6.1 Overview

9.6.2 Plasma Fractionation Companies: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)

10. MEA Blood Transfusion Diagnostics Market Analysis – Country Analysis

10.1 Overview

10.1.2 MEA: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)

10.1.2.1 South Africa: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.1 Overview

10.1.2.1.2 South Africa Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.3 South Africa: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

10.1.2.1.4 South Africa: Metabolomics Market Revenue and Forecasts To 2028, By Application (US$ Million)

10.1.2.1.5 South Africa: Metabolomics Market Revenue and Forecasts To 2028, By End User (US$ Million)

10.1.2.2 Saudi Arabia: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.1 Overview

10.1.2.2.2 Saudi Arabia Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.3 Saudi Arabia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

10.1.2.2.4 Saudi Arabia: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By Application (US$ Million)

10.1.2.2.5 Saudi Arabia: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By End User (US$ Million)

10.1.2.3 UAE: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.1 Overview

10.1.2.3.2 UAE: Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.3 UAE: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

10.1.2.3.4 UAE: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By Application (US$ Million)

10.1.2.3.5 UAE: Blood Transfusion Diagnostics Market Revenue and Forecasts To 2028, By End User (US$ Million)

10.1.2.4 Rest of the MEA: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.1 Overview

10.1.2.4.2 Rest of the MEA Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.3 Rest of MEA: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

10.1.2.4.4 Rest of MEA: Metabolomics Market Revenue and Forecasts To 2028, By Application (US$ Million)

10.1.2.4.5 Rest of MEA: Metabolomics Market Revenue and Forecasts To 2028, By End User (US$ Million)

11. Industry Landscape

11.1 Overview

11.2 Inorganic Growth Strategies

11.2.1 Overview

11.3 Organic Growth Strategies

11.3.1 Overview

12. Company Profiles

12.1 Grifols, S.A.

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 F. Hoffmann-La Roche Ltd

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Immucor, Inc.

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Bio-Rad Laboratories, Inc.

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Abbott

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Thermo Fisher Scientific Inc.

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Ortho Clinical Diagnostics (QuidelOrtho Corporation)

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 DiaSorin S.p.A.

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Quotient Limited

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 BAG Diagnostics GmbH

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES.

Table 1. MEA Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Mn)

Table 2. South Africa Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 3. South Africa: Metabolomics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 4. South Africa: Metabolomics Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 5. Saudi Arabia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 6. Saudi Arabia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 7. Saudi Arabia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 8. UAE: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 9. UAE: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 10. UAE: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 11. Rest of MEA: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 12. Rest of MEA: Metabolomics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 13. Rest of MEA: Metabolomics Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 14. Recent Inorganic Growth Strategies

Table 15. Recent Organic Growth Strategies

Table 16. Glossary of Terms

The List of Companies - Middle East & Africa Blood Transfusion Diagnostics Market

● Abbott

● BAG Diagnostics GmbH

● Bio-Rad Laboratories, Inc.

● DiaSorin S.p.A.

● F. Hoffmann-La Roche Ltd      

● Grifols, S.A.  

● Immucor, Inc.  

● Ortho Clinical Diagnostics (QuidelOrtho Corporation)

● Quotient Limited

● Thermo Fisher Scientific Inc.

Reason To Buy

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the MEA blood transfusion diagnostics market.

● Highlights key business priorities to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the MEA blood transfusion diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the blood transfusion diagnostics market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

AVAILABLE CUSTOMIZATION RESEARCH METHODOLOGY REQUEST FOR TOC FREE SAMPLE REPORT
CHOOSE LICENCE TYPE
(Middle East & Africa Blood Transfusion Diagnostics Market Forecast to 2028)
  • Single User Price $3,000$2,400
  • Site Price $4,000$3,200
  • Enterprise Price $5,000$4,000
Buy Now Add to Cart
REQUEST FOR TOC
SPEAK TO ANALYST
FREE SAMPLE
REPORT
INQUIRE BEFORE
BUYING
TOP
Quick Enquiry